4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001831749-26-000002
Options or other derivatives
- Chief Scientific Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bellon Steven F. Chief Scientific Officer | 2026-01-30 | Grant or award · Stock Option (right to buy) | +300,000 | $5.71 | $1,713,000 | 300,000 | D |
Loading xslF345X05/primarydocument.xml…